MENU
ORIC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oric Pharmaceuticals (ORIC) Earnings Date & Reports
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
A.I. Advisor
published Earnings
ORIC is expected to report earnings to rise 9.09% to -37 cents per share on November 09
Q3'26
Est.
$-0.37
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.07
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
The last earnings report on May 04 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 414.04K shares outstanding, the current market capitalization sits at 1.42B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
Profile
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
104
Web
https://www.oricpharma.com